Licensing agreements between pharmaceutical companies and the Medicines Patent Pool, in cooperation with the WHO, could accelerate access to doses for the poorest countries
The great game in the global economy, which consisted in large numbers of countries sitting down to negotiate vast free trade and investment agreements, has suddenly been reversed